Neuromuscular manifestations of Graves' disease.
D000328:Adult; D000917:Antibody Formation; D005260:Female; D006111:Graves Disease / Q000150:complications* / Q000276:immunology; D006801:Humans; D008297:Male; D008931:Mitochondria, Muscle; D009132:Muscles / Q000473:pathology; D009133:Muscular Atrophy / Q000209:etiology; D009135:Muscular Diseases / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000150:complications / Q000276:immunology; D009210:Myofibrils; D009468:Neuromuscular Diseases / Q000209:etiology*; D010085:Oxidative Phosphorylation; D010243:Paralysis / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D011188:Potassium / Q000378:metabolism; D012519:Sarcoplasmic Reticulum; D013963:Thyroid Hormones / Q000494:pharmacology
D013963:Thyroid Hormones; D011188:Potassium